Vaxil Bio Ltd.
VXL.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 317.50K | 345.60K | -79.00K | -100.40K | -100.40K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -444.80K | -446.90K | -21.50K | -18.70K | -18.70K |
| Change in Net Operating Assets | -25.90K | 18.80K | -12.60K | -14.80K | -14.80K |
| Cash from Operations | -153.20K | -82.40K | -113.00K | -133.80K | -192.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 191.90K | 191.90K | 92.20K | 0.00 | 0.00 |
| Cash from Investing | 191.90K | 191.90K | 92.20K | 0.00 | -182.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 127.00K | 127.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 91.10K | 91.10K | -- | -- | -- |
| Foreign Exchange rate Adjustments | 0.00 | 1.40K | 0.00 | 800.00 | 800.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 129.80K | 201.90K | -21.00K | -133.20K | -375.10K |